In the quest to outshine the broader market, stock pickers diligently seek out stocks with the potential for superior performance. Making the right choices can significantly elevate your wealth.
UiPath Inc (NYSE: PATH) closed the day trading at $15.97 down -7.37% from the previous closing price of $17.24. In other words, the price has decreased by -$7.37 from its previous closing price. On the day, 49.53 million shares were traded. PATH stock price reached its highest trading level at $17.5223 during the session, while it also had its lowest trading level at $15.5.
Ratios:
For a better understanding of PATH, let’s look at its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 6.11 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 27.41. For the most recent quarter (mrq), Quick Ratio is recorded 2.54 and its Current Ratio is at 2.54. In the meantime, Its Debt-to-Equity ratio is 0.04 whereas as Long-Term Debt/Eq ratio is at 0.04.
Upgrades & Downgrades
In the most recent recommendation for this company, BMO Capital Markets on October 02, 2025, Reiterated its Market Perform rating but revised its target price to $13 from $12.50 previously.
BMO Capital Markets reiterated its Market Perform rating for the stock on September 05, 2025, while the target price for the stock was revised from $15.50 to $12.50.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Jan 13 ’26 when Dines Daniel sold 45,000 shares for $17.18 per share. The transaction valued at 773,208 led to the insider holds 28,118,585 shares of the business.
Dines Daniel sold 45,000 shares of PATH for $747,432 on Jan 12 ’26. The CEO and Chairman now owns 28,163,585 shares after completing the transaction at $16.61 per share. On Jan 09 ’26, another insider, Dines Daniel, who serves as the CEO and Chairman of the company, sold 45,000 shares for $17.17 each. As a result, the insider received 772,736 and left with 28,208,585 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, PATH now has a Market Capitalization of 8539952640 and an Enterprise Value of 7223775232. As of this moment, UiPath’s Price-to-Earnings (P/E) ratio for their current fiscal year is 37.67, and their Forward P/E ratio for the next fiscal year is 21.03. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 1.34. For the stock, the TTM Price-to-Sale (P/S) ratio is 5.50 while its Price-to-Book (P/B) ratio in mrq is 4.44. Its current Enterprise Value per Revenue stands at 4.651 whereas that against EBITDA is 198.592.
Stock Price History:
The Beta on a monthly basis for PATH is 1.08, which has changed by 0.28945398 over the last 52 weeks, in comparison to a change of 0.1726681 over the same period for the S&P500. Over the past 52 weeks, PATH has reached a high of $19.84, while it has fallen to a 52-week low of $9.38. The 50-Day Moving Average of the stock is 1.86%, while the 200-Day Moving Average is calculated to be 20.48%.
Shares Statistics:
Over the past 3-months, PATH traded about 24.07M shares per day on average, while over the past 10 days, PATH traded about 29982520 shares per day. A total of 460.35M shares are outstanding, with a floating share count of 406.74M. Insiders hold about 23.94% of the company’s shares, while institutions hold 55.58% stake in the company. Shares short for PATH as of 1767139200 were 51880630 with a Short Ratio of 2.16, compared to 1764288000 on 48479105. Therefore, it implies a Short% of Shares Outstanding of 51880630 and a Short% of Float of 14.149999999999999.
Earnings Estimates
The firm’s stock currently is rated by 20.0 analysts. The consensus estimate for the next quarter is $0.15, with high estimates of $0.19 and low estimates of $0.11.
Analysts are recommending an EPS of between $0.69 and $0.63 for the fiscal current year, implying an average EPS of $0.67. EPS for the following year is $0.76, with 22.0 analysts recommending between $0.94 and $0.65.
Revenue Estimates
17 analysts predict $464.76M in revenue. The current quarter. It ranges from a high estimate of $466.3M to a low estimate of $464M. As of. The current estimate, UiPath Inc’s year-ago sales were $423.65MFor the next quarter, 17 analysts are estimating revenue of $392.84M. There is a high estimate of $407.34M for the next quarter, whereas the lowest estimate is $380.69M.
A total of 19 analysts have provided revenue estimates for PATH’s current fiscal year. The highest revenue estimate was $1.6B, while the lowest revenue estimate was $1.59B, resulting in an average revenue estimate of $1.59B. In the same quarter a year ago, actual revenue was $1.43BBased on 21 analysts’ estimates, the company’s revenue will be $1.74B in the next fiscal year. The high estimate is $1.77B and the low estimate is $1.72B.
